Insider filing · SYRE
Heidy King-Jones
See Remarks
profile →
Spyre Therapeutics, Inc.
SYRE · Healthcare · 32 filings in 24 months
ticker →
Heidy King-Jones sold $2.6M of Spyre Therapeutics (SYRE)
Executed Oct 1, disclosed Oct 3, 1 day later.
Value, as filed
$2.6M
28,533 sh across 4 lots
Executed
Oct 1
the trade date, as filed
Disclosed
Oct 3
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HJHeidy King-Jones (See Remarks) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $2.6M of SYRE (28,533 sh across 4 lots, as filed), executed Oct 1.
The name
SYREHealthcare · Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Heidy King-Jones in SYRE
SYRESALE
Spyre Therapeutics, Inc.
$2.4M27,599 sh across 3 lots
Exec Sep 1
Filed Sep 3 · 9:34 PM ET